Cited by 27Medical Imaging and Pathology StudiesSarcoidosis and Beryllium Toxicity ResearchInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

The DOI matches its Crossref record; its reference list is not available.

A novel SLC34A2 mutation in a patient with pulmonary alveolar microlithiasis

Open access

Abstract

Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive disease caused by mutations in SLC34A2 and characterized by intra-alveolar accumulation of microliths. We diagnosed a case of PAM in a 27-year-old Japanese female and identified a novel mutation in SLC34A2 (c.1390 G>C [G464R] in exon 12).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/hgv.2016.47

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Slc34a2 gene participates in the transportation of phosphate released from phospholipids during pulmonary surfactant recycling.

    “This gene participates in the transportation of phosphate released from phospholipids during pulmonary surfactant recycling (Izumi et al., 2017), thus also plays an important role in the development of pulmonary surfactants.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 16 · Cited by 27

Research works printed but not linked: 16

  1. Tachibana T, Hagiwara K, Johkoh T . Pulmonary alveolar microlithiasis: review and management. Curr Opin Pulm Med 2009; 15: 486–490. · DOI
  2. Corut A, Senyigit A, Ugur SA, Altin S, Ozcelik U, Calisir H et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 2006; 79: 650–656. · DOI
  3. Vismara MFM, Colao E, Fabiani F, Bombardiere F, Tamburrini O, Alessio C et al. The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3. Respir Med Case Rep 2015; 16: 77–80.
  4. Castellana G, Castellana G, Gentile M, Castellana R, Resta O . Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide. Eur Respir Rev 2015; 24: 607–620. · DOI
  5. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248–249. · DOI · Paper page
  6. Schwarz JM, Cooper DN, Schuelke M, Seelow D . MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014; 11: 361–362. · DOI · Paper page
  7. Huqun S, Izumi S, Miyazawa H, Ishii K, Uchiyama B, Ishida T et al. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 2007; 175: 263–268. · DOI
  8. Proesmans M, Boon M, Verbeken E, Ozcelik U, Kiper N, Van De Casseye W et al. Pulmonary alveolar microlithiasis: a case report and review of the literature. Eur J Pediatr 2012; 171: 1069–1072. · DOI
  9. Jönsson ÅLM, Hilberg O, Bendstrup EM, Mogensen S, Simonsen U . SLC34A2 gene mutation may explain comorbidity of pulmonary alveolar microlithiasis and aortic valve sclerosis. Am J Respir Crit Care Med 2012; 185: 464. · DOI
  10. Ishihara Y, Hagiwara K, Zen K, Huqun, Hosokawa Y, Natsuhara A . A case of pulmonary alveolar microlithiasis with an intragenetic deletion in SLC34A2 detected by a genome-wide SNP study. Thorax 2009; 64: 365–367. · DOI
  11. Dogan O, Ozsahin SL, Gul E, Arslan S, Koksal B, Berk S et al. A frame-shift mutation in the SLC34A2 gene in three patients with pulmonary alveolar microlithiasis in an inbred family. Intern Med 2010; 49: 45–49. · DOI
  12. Zhong YQ, Hu CP, Cai XD, Nie HP . A novel mutation of the SLC34A2 gene in a Chinese pedigree with pulmonary alveolar microlithiasis. Chinese J Med Genet 2009; 26: 365–368.
  13. Ma T, Ren J, Yin J, Ma Z . A pedigree with pulmonary alveolar microlithiasis: a clinical case report and literature review. Cell Biochem Biophys 2014; 70: 565–572. · DOI
  14. Ozbudak IH, Bassorgun CI, Ozbilim G, Luleci G, Sarper A, Erdogan A et al. Pulmonary alveolar microlithiasis with homozygous c.316g>C (p.G106R) mutation: a case report. Turk Patoloji Derg 2012; 28: 282–285.
  15. Proesmans M, Boon M, Verbeken E, Ozcelik U, Kiper N, Van DCW et al. Pulmonary alveolar microlithiasis: a case report and review of the literature. Eur J Pediatr 2012; 171: 1069–1072. · DOI
  16. Wang H, Yin X, Wu D, Jiang X . SLC34A2 gene compound heterozygous mutation identification in a patient with pulmonary alveolar microlithiasis and computational 3D protein structure prediction. Meta Gene 2014; 2: 557–564. · DOI

Metadata

Authors
Izumi, H., Kurai, J., Kodani, M., Watanabe, M., Yamamoto, A., Nanba, E., Adachi, K., Igishi, T., & Shimizu, E.
Affiliations
Tottori University (JP)
Corresponding author
Izumi, Hiroki
Venue
Human Genome Variation
Published
2017-01-26
Volume
4
Issue
1
Pages
16047-16047
ISSN
2054-345X (ISSN-L)
OpenAlex
W2582733697
Cited by
27
References
16
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 4 · 2017: 3
FWCI
3.17
Type
journal article
Language
en
Open access
Locations
  • Human Genome Variation (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Japan Society for the Promotion of Science (26461159)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Medical Imaging and Pathology Studies
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Sarcoidosis and Beryllium Toxicity Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Keywords
pulmonary alveolar microlithiasis, SLC34A2, novel mutations, autosomal recessive inheritance, microliths, genetic diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review